<DOC>
	<DOCNO>NCT02249481</DOCNO>
	<brief_summary>Open-labelled , randomise control trial . Patients assess pre-operatively , 24 48 hour primary outcome secondary outcome ( except Oxford Knee Score assess pre-operatively 6 month post-operatively ortho-paedic team ) . Primary Objective : To demonstrate whether adductor canal nerve infusion result superior patient mobilisation within first 48 hour follow total knee replacement compare femoral nerve catheter infusion . Secondary Objective : To identify whether adductor canal nerve infusion result superior analgesia within first 48 hour follow total knee replacement compare femoral nerve catheter infusion .</brief_summary>
	<brief_title>A Comparison Anaesthetic Methods Total Knee Replacement Surgery</brief_title>
	<detailed_description>We compare continuous adductor canal block low concentration continuous femoral nerve block . We currently use low dose femoral nerve catheter base technique part standard treatment strategy total knee arthroplasty . The use catheter provide prolonged analgesia compare single shot block , also allow low concentration local anaesthetic employ , thus potentially reduce incidence motor blockade . The concentration local anaesthetic employ routine practice ( 0.0625 % L- Bupivacaine ) lower routinely use many centre , clinical study compare high concentration local anaesthetic - might expect produce motor blockade . The concentration use high minimum effective concentration femoral catheter infusion knee arthroplasty .</detailed_description>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<criteria>Subject diagnosis rheumatoid osteoarthritis list primary total knee replacement . Participant willing able give inform consent participation study . Male Female , age 18 85 year . American Society Anesthesiologists ( ASA ) score IIII Able ( clinical staff 's opinion ) willing comply study requirement . Willing allow General Practitioner consultant , appropriate , notified participation study . Patient refusal Chronic pain ( define consumption &gt; 480mg codeine/24hrs ANY regular strong opiate consumption oral/transdermal route ) Patients age &lt; 18 &gt; 85 ASA score &gt; III Body mass index ( BMI ) &gt; 35 Lacking mental capacity give consent enter trial/undergo surgery Contraindications catheter placement ( coagulopathy , systemic sepsis infection placement site , preexist neuropathy ) component study treatment pathway . Participant terminally ill Allergy/intolerance study medication Any significant disease disorder , opinion Investigator , may either put participant risk participation study , may influence result study , participant 's ability participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Anaesthetic</keyword>
	<keyword>total knee replacement</keyword>
	<keyword>Femoral nerve catheter</keyword>
	<keyword>Adductor canal catheter</keyword>
</DOC>